Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer

Exclusion Criteria

• •History of prior myocardial infarction or arrhythmia
• •History of any condition deemed by the principal investigator to be a contraindication to B-WARM therapy (e.g., skin reaction, dysregulation of thermoregulation, etc)
• •All patients with transdermal patches (e.g.; fentanyl, Lidoderm, scopolamine, etc)
• •Pregnant or nursing female patients
• •Unwilling or unable to follow protocol requirements
• •Any condition which in the investigator's opinion deems the patient an unsuitable candidate to receive B-WARM
• •Received an investigational agent within 30 days prior to enrollment
• •Received any systemic therapy within 21 days prior to planned B-WARM therapy
• •* Patients may be enrolled on study but at least 21 days should elapse prior to date of B-WARM therapy
• •Patients should not have either CT scanning or B-WARM if they have a fever at the time
• •* Fever should be worked up and treated as appropriate
• •* Patients should be afebrile for 24 hours prior to scanning or B-WARM therapy